EYE CHOOSE: An economic evaluation of surgical strategies for retinal detachment
This study combines a systematic review, network meta-analysis, and economic modeling to conclude that while evidence remains limited, pneumatic retinopexy (PnR) appears to be the most cost-effective surgical strategy for managing rhegmatogenous retinal detachment, offering better vision at a lower cost compared to pars plana vitrectomy and scleral buckle.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human eye relies on a delicate, transparent layer at the back called the retina to capture images and send them to the brain. When a tear or hole forms in this layer, fluid can seep underneath, causing the retina to peel away from the back of the eye. This condition, known as retinal detachment, is a medical emergency that threatens sight and requires urgent surgery to reattach the tissue. Without intervention, the vision loss can become permanent. In the United Kingdom, where this condition affects roughly sixteen people out of every 100,000 annually, doctors currently have three main ways to fix the problem. One method involves a keyhole surgery to remove the jelly-like substance inside the eye and drain the fluid. Another uses an external band to gently reshape the eye wall, encouraging the retina to settle back into place. The third approach injects a tiny gas bubble into the eye, which the patient must position carefully against the tear to push the retina back. While the first method is used most often in hospitals, emerging signs suggest the gas bubble technique might offer better results for patients, raising a critical question for healthcare systems: which of these three surgeries provides the best care for the money spent?
A team of researchers set out to answer this by gathering every available piece of high-quality evidence comparing these three surgical strategies. They focused specifically on randomized controlled trials, which are studies where patients are randomly assigned to different treatments, ensuring a fair comparison. The team sifted through thousands of records to find fifteen such studies that directly compared the outcomes of the keyhole surgery, the external band, and the gas bubble injection. They analyzed data on how well vision was restored, how often the retina stayed attached after the first operation, and what complications, such as cataracts, developed afterward. To understand the financial impact, they built a detailed economic model using current costs from the National Health Service. This model calculated not just the price of the surgery itself, but also the costs associated with managing complications and the value of the vision gained, measuring success in terms of lines read on a standard eye chart.
The analysis revealed a clear pattern in the data. The gas bubble injection, known as pneumatic retinopexy, consistently emerged as the most effective option for restoring vision. Patients who received this treatment were more likely to achieve a level of sight that allows for activities like driving, compared to those who underwent the other two procedures. While the keyhole surgery had a slightly higher chance of successfully reattaching the retina on the very first attempt, the gas bubble method still performed very well in this regard and offered a significant advantage in visual outcomes. Perhaps most importantly, the gas bubble approach was far less expensive. It cost less than half as much as the other two methods, largely because it is a simpler procedure that does not require the same level of surgical equipment or operating time. When the researchers combined the lower cost with the better vision results, the gas bubble injection dominated the other options, meaning it was both cheaper and more effective.
The team tested their findings rigorously to ensure they held up under different assumptions. They adjusted the numbers to account for uncertainty, such as the possibility that some patients might need a second laser treatment after the gas bubble injection, or variations in how often complications occur. Even with these changes, the conclusion remained the same: the gas bubble injection offered the best value. The researchers noted that while the evidence was strong, it was not perfect. There were fewer studies comparing the gas bubble method directly to the others, and some of the existing studies had limitations in how they reported their results. However, the data available was sufficient to show a strong signal that the gas bubble technique is a highly cost-effective choice. The study suggests that healthcare decision-makers should consider expanding the use of this simpler, cheaper, and visually superior treatment for the right patients, rather than relying almost exclusively on the more expensive keyhole surgery that is currently the standard.
Ultimately, this work provides a clear roadmap for improving eye care. By synthesizing the best available evidence, the study demonstrates that a less invasive, lower-cost procedure can deliver better sight for patients with retinal detachment. While more research is needed to fully understand the long-term effects and to compare all three methods in a single, large-scale trial, the current evidence points toward a shift in practice. For patients facing the sudden threat of losing their sight, the gas bubble injection represents a promising path forward, offering a chance to see clearly again without the heavy financial burden associated with more complex surgeries.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.